Taiwan Biotech Delegation Showcases Regional Innovation in CDMO, Cell Therapy, and Biologics at BioJapan 2026
YOKOHAMA, Japan, Oct. 6, 2026 /PRNewswire/ -- Highlighting regional life sciences innovation, 17 Taiwanese biotech companies and research institutions are gathering at BioJapan 2026 (Oct. 7 to 9) to showcase breakthrough capabilities across high-growth verticals, including advanced CDMO, cell therapy, and biologics. Welcome to Join Cheers & Collab! Led by the Biotechnology and Pharmaceutical Industries Promotion Office...
Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue
Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance Period BEIJING, Oct. 5, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic intelligence and AI-powered multimodal and agent-based digital solutions, today announced its...
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform LONDON, ON and HERZLIYA, Israel, Oct. 5, 2026 /PRNewswire/ -- EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation. The collaboration combines EpiSign's expertise in DNA methylation episignature...
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on October 5th The Estée Lauder...
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.
OMLYCLO® (omalizumab-igec) is the first and onlyFDA-approved omalizumab biosimilar approved for all four indications of XOLAIR® (omalizumab) and designated as interchangeable with XOLAIR; OMLYCLO® will be available in 75 mg/0.5 mL, 150 mg/mL and 300mg/2mL in a single-dose prefilled syringe for subcutaneous injection in the U.S. The availability of the first...
Habitat for Humanity’s new global research report finds three in four people are cutting back on essentials to afford housing
ATLANTA, Oct. 5, 2026 /PRNewswire/ -- Housing costs are forcing millions of people around the world into difficult trade-offs, coming at the expense of food, healthcare, financial security and major plans for the future, according to a global research report released today by Habitat for Humanity International. Titled Home at What...
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization
Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers navigating increasingly demanding development and manufacturing challenges TOKYO, Oct. 5, 2026 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a global network of specialized contract development and manufacturing organizations (CDMOs) and enabling technologies, today unveiled a refreshed global...
Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea
TAIPEI, Oct. 5, 2026 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has signed a Memorandum of Understanding ("MOU") with Yoo Young Pharm. Co., Ltd. ("YYP"), a South Korea-based pharmaceutical company, to explore a collaboration for the development, registration, and commercialization of ENERGI-F703DFU in Korea. Under the MOU, the parties intend to work toward...
From Run Clubs to the Nation: ELDON partners with KBS to extend the Spirit of “Wellness On and On” to Hari Sukan Negara 2026
Malaysian health and wellness brand ELDON partners with Ministry of Youth and Sports Malaysia (KBS) to bring its "Wellness On and On" movement from local running clubs to a national platform targeting 5.3 million participants KUALA LUMPUR, Malaysia, Oct. 5, 2026 /PRNewswire/ -- ELDON (also known as Eldon Healthcare), the homegrown health and wellness brand of Pharm-D Health...
EVIDENT Completes Acquisition of CrestOptics S.p.A.
NEEDHAM, Mass., Oct. 5, 2026 /PRNewswire/ -- Evident announced today that it has completed the acquisition of CrestOptics S.p.A., a Rome-based developer and manufacturer of advanced optical imaging systems for spinning disk confocal and super-resolution microscopy. The acquisition broadens Evident's life science imaging portfolio and deepens its capability in high-speed, high-content...
